$RSPI .0068 wow! up 750% >> grabbed 4m at .0014 Now loving the ride $$$ >> With funding from DOD, this is guaranteed to fly into the SILVER range. RespireRx Pharmaceuticals Inc. Announces a Department of Defense Award to Fund a Phase 2 Clinical Study to Determine the Safety and Efficacy of CX1739, its Lead AMPAkine, to Improve Bladder Function in Patients with Spinal Cord Injury
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.